Opening of Russia office

EASTPHARMA LTD. Subject: Opening of Russia office London, 15 November 2007 - Hereunder is the announcement made on 15 November 2007 by EastPharma's subsidiary Deva Holding A.S. to the Administration of the Istanbul Stock Exchange in accordance with the Capital Markets Board's communiqué serial VIII, No:39: Deva Holding A.S. announces the successful opening of its authorized representative office in Moscow. The launch of the Moscow office is a further step in EastPharma's expansion strategy, which is focused on the high growth pharmaceutical markets of Turkey, the former Soviet Union, Eastern Europe and surrounding regions. The Moscow office is now responsible for the registration of pharmaceutical products in Russia and the liaison mission with Russian Health Authorities. Russia is one of the fastest growing pharmaceutical markets in EastPharma's target region. The Russian pharmaceutical market was worth US$10.6bn in 2006, up from US$8.4bn in 2005, according to the Association of International Pharmaceutical Manufacturers in Russia. The office will initially register the selected products from Deva's range of 217 products as well as those of Saba, the Turkish pharmaceutical producer acquired by EastPharma in May 2007, with the Russian pharmaceutical licensing authorities during the course of 2007. Baki Taskiran, CEO of EastPharma, said: "Russia is a fast growing pharmaceutical market. A local presence provides EastPharma with a base from which to develop sales into Russia and understand the dynamics shaping the market as well as regulatory developments in the country". The Moscow representative office's contact details are as follows: Russian Federation, 109316, Moscow, Ostapovsky Proezd 5, Stroyenie 1, Office 811". For further information, please contact: EastPharma Limited Idil Bora - Investor Relations Tel.: + 90 (212) 6929326 ---END OF MESSAGE---